JG
ZYNE

Jefferies Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Jefferies Group’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-70,500
Closed -$1.2M – 2683
2017
Q2 		$1.2M Buy
70,500
+500
+0.7% +$9.94K 0.01% 1205
2017
Q1 		$1.41M Buy
+70,000
New +$1.39M 0.01% 1091

Other funds holding ZYNE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FTIOP
Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jefferies Group's ZYNE Position: Q4 2017 in Review

Jefferies Group sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2017, closing a stake of 5,951 shares — an estimated $50K sold.

Jefferies Group first reported a position in ZYNE in Q1 2017 and held it in 3 quarters. The position peaked at $1.15M in Q1 2017. 64 funds tracked by Wall St. Rank hold ZYNE as of Q4 2017.

  • Jefferies Group reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2017 after selling out during the quarter.
  • Jefferies Group sold 5,951 Zynerba Pharmaceuticals, Inc shares in Q4 2017, an estimated $50K.
  • Jefferies Group first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2017 and held it in 3 quarters.
  • Jefferies Group's Zynerba Pharmaceuticals, Inc position peaked at $1.15M in Q1 2017.
  • 64 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.